IDEXX Laboratories, Inc. (IDXX)
676.21
-13.44
(-1.95%)
USD |
NASDAQ |
Nov 20, 16:00
676.47
+0.26
(+0.04%)
After-Hours: 20:00
IDEXX Laboratories Research and Development Expense (TTM) : 266.87M for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 266.87M |
| June 30, 2026 | 261.46M |
| March 31, 2026 | 257.93M |
| December 31, 2025 | 251.21M |
| September 30, 2025 | 242.10M |
| June 30, 2025 | 232.67M |
| March 31, 2025 | 226.22M |
| December 31, 2024 | 219.79M |
| September 30, 2024 | 213.88M |
| June 30, 2024 | 207.86M |
| March 31, 2024 | 198.92M |
| December 31, 2023 | 190.95M |
| September 30, 2023 | 182.56M |
| June 30, 2023 | 182.60M |
| March 31, 2023 | 259.32M |
| December 31, 2022 | 254.82M |
| September 30, 2022 | 256.71M |
| June 30, 2022 | 249.12M |
| March 31, 2022 | 163.60M |
| December 31, 2021 | 161.01M |
| September 30, 2021 | 154.48M |
| June 30, 2021 | 151.57M |
| March 31, 2021 | 145.52M |
| December 31, 2020 | 141.25M |
| September 30, 2020 | 137.63M |
| Date | Value |
|---|---|
| June 30, 2020 | 134.38M |
| March 31, 2020 | 134.99M |
| December 31, 2019 | 133.19M |
| September 30, 2019 | 128.17M |
| June 30, 2019 | 123.10M |
| March 31, 2019 | 120.35M |
| December 31, 2018 | 117.86M |
| September 30, 2018 | 116.53M |
| June 30, 2018 | 114.93M |
| March 31, 2018 | 112.42M |
| December 31, 2017 | 109.18M |
| September 30, 2017 | 105.79M |
| June 30, 2017 | 103.88M |
| March 31, 2017 | 102.29M |
| December 31, 2016 | 101.12M |
| September 30, 2016 | 101.20M |
| June 30, 2016 | 100.39M |
| March 31, 2016 | 99.30M |
| December 31, 2015 | 99.68M |
| September 30, 2015 | 99.05M |
| June 30, 2015 | 99.04M |
| March 31, 2015 | 100.16M |
| December 31, 2014 | 98.26M |
| September 30, 2014 | 95.89M |
| June 30, 2014 | 92.61M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Becton, Dickinson & Co. | 1.059B |
| Intuitive Surgical, Inc. | 1.493B |
| Zimmer Biomet Holdings, Inc. | 432.90M |
| Globus Medical, Inc. | 143.52M |
| Phibro Animal Health Corp. | -- |